Digital Health Technologies in Oncology

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 474

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medical Informatics and Biostatistics, “Iuliu Haţieganu” University of Medicine and Pharmacy, Louis Pasteur Str., No. 6, 400349 Cluj-Napoca, Romania
Interests: applied and computational statistics; molecular modeling; genetic analysis; statistical modeling in medicine; integrated health informatics system; medical diagnostic research; statistical inference; medical imaging analysis; assisted decision systems; research ethics; social media and health information; evidence-based medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Digital health technologies have started to play a fundamental role in healthcare by enhancing patient diagnosis and (remote) monitoring, streamlining processes, enabling precision medicine with data analytics, and improving healthcare access through telemedicine. As the healthcare landscape evolves, digital innovations are transforming cancer care, from early detection to precision treatment, monitoring and patient support.

We invite researchers, clinicians, and technologists to share their insights, studies, and innovations in digital health technologies applied in cancer management. Topics of interest include but are not limited to AI-driven diagnostics, telemedicine, wearable devices, and data analytics.

Do not miss this opportunity to contribute to the advancement of cancer care through digital health technologies. Submit your cutting-edge research today and shape the future of oncology.

Prof. Dr. Sorana D. BOLBOACĂ
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • digital healthcare
  • digital health technologies
  • diagnosis
  • wearable devices
  • rehabilitation technologies
  • assistive technologies
  • robotic surgery
  • (remote) monitoring
  • precision medicine
  • data analytics
  • healthcare teleassistance
  • AI-driven diagnostics and monitoring
  • AI-driven analytics

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 1302 KiB  
Article
Internet Access and Use by Patients with Gynecologic Malignancies: A Cross-Sectional Study
by Frederik Bach, David Engelhardt, Christoph A. Mallmann, Sina Tamir, Lars Schröder, Christian M. Domröse and Michael R. Mallmann
Cancers 2024, 16(9), 1677; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers16091677 - 26 Apr 2024
Viewed by 158
Abstract
The influence of digitalization on information-seeking, decision-making properties of patients, therapy monitoring, and patient–physician interactions has and will change the global health sector tremendously. With this study, we add knowledge on the degree of digitalization, digital device availability, the use and availability of [...] Read more.
The influence of digitalization on information-seeking, decision-making properties of patients, therapy monitoring, and patient–physician interactions has and will change the global health sector tremendously. With this study, we add knowledge on the degree of digitalization, digital device availability, the use and availability of home and mobile internet access, and the willingness to use novel forms of patient–physician interactions in a group of gynecologic cancer patients. From July 2017 to March 2022, 150 women with a diagnosis of gynecologic malignancy at the University Hospital of Cologne participated in this questionnaire-based cohort study. Any one of three potential internet access devices (stationary computer, smartphone, or tablet) is owned by 94% of patients and the only patient intrinsic factor that is significantly associated with the property of any one of these internet access devices is age. The Internet is used daily or several times per week to assess information on their disease by 92.8%, 90.1% use the Internet for communicational purposes and 71.9% and 93.6% are willing to communicate with their treating physicians via E-Mail or even novel forms of communication, respectively. In conclusion, the predominant majority of gynecologic cancer patients can be reached by modern internet-based E-Health technologies. Full article
(This article belongs to the Special Issue Digital Health Technologies in Oncology)
Show Figures

Figure 1

Back to TopTop